Homeostatic Role of Decorin in Right Ventricular Pressure Overload and Pulmonary Hypertension Induced Remodeling
Open Access
- 18 December 2024
- journal article
- Published by Elsevier in JACC: Basic To Translational Science
- Vol. 10 (3) , 323-341
Abstract
No abstract availableKeywords
Funding Information
- Heart and Stroke Foundation of Canada
- Canadian Institutes of Health Research
This publication has 60 references indexed in Scilit:
- Integrated analysis of multimodal single-cell dataCell, 2021
- Asymmetric Regional Work Contributes to Right Ventricular Fibrosis, Inefficiency, and Dysfunction in Pulmonary Hypertension versus RegurgitationJournal of the American Society of Echocardiography, 2021
- Injectable hyaluronic acid based microrods provide local micromechanical and biochemical cues to attenuate cardiac fibrosis after myocardial infarctionBiomaterials, 2018
- Decorin as a multivalent therapeutic agent against cancerAdvanced Drug Delivery Reviews, 2016
- Prognostic significance of 2-dimensional, M-mode, and Doppler echo indices of right ventricular function in children with pulmonary arterial hypertensionAmerican Heart Journal, 2013
- Stereology of the Lung2013
- Decorin transfection suppresses profibrogenic genes and myofibroblast formation in human corneal fibroblastsExperimental Eye Research, 2010
- Decorin-mediated Transforming Growth Factor-β Inhibition Ameliorates Adverse Cardiac RemodelingThe Journal of Heart and Lung Transplantation, 2007
- Effects of rhDecorin on TGF-β1 induced human hepatic stellate cells LX-2 activationBiochimica et Biophysica Acta (BBA) - General Subjects, 2006
- Reverse remodeling following insertion of left ventricular assist devices (LVAD): A review of the morphological and molecular changesCardiovascular Research, 2005